NEW YORK (GenomeWeb) – HTG Molecular Diagnostics said this week that it received formal notice from the Nasdaq stock market on April 12 indicating that the Nasdaq Hearings Panel had granted the company's request to transfer the listing of its common stock from the Nasdaq Global Market to the Nasdaq Capital Market. The intra-market transfer was effective on April 17.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.